Source link : https://www.newshealth.biz/health-news/hipec-for-recurrent-platinum-sensitive-ovarian-cancer-fails-to-improve-pfs/
Patients with recurrent platinum-sensitive ovarian cancer did just as well with cytoreductive surgery alone as they did with surgery plus intraperitoneal chemotherapy, according to a randomized trial. Median progression-free survival (PFS) improved from 23 months with surgery alone to 25 months with the addition of hyperthermic intraperitoneal chemotherapy (HIPEC), a nonsignificant difference. Post-recurrence survival (PRS) […]
Author : News Health
Publish date : 2024-12-03 20:55:45
Copyright for syndicated content belongs to the linked Source.